Author:
KAYABAŞI Çağla,YILMAZ SÜSLÜER Sunde,BALCI Tuğçe,ÖZMEN YELKEN Besra,MUTLU Zeynep,ÇALIŞKAN KURT Cansu,GOKER BAGCA Bakiye,BİRAY AVCI Çığır,GÜNDÜZ Cumhur
Publisher
Uludag Universitesi Tip Fakultesi Dergisi
Reference37 articles.
1. 1. Arya GC, Kaur K, Jaitak V. Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies. Eur J Med Chem 2021;221:113511.
2. 2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69(1):7-34.
3. 3. Lumachi F, Santeufemia DA, Basso SM. Current medical treatment of estrogen receptor-positive breast cancer. World J Biol Chem 2015;6(3):231-9.
4. 4. Eric I, Petek Eric A, Kristek J, Koprivcic I, Babic M. Breast Cancer in Young Women: Pathologic and Immunohistochemical Features. Acta Clin Croat 2018;57(3):497-502.
5. 5. Dickson C, Spencer-Dene B, Dillon C, Fantl V. Tyrosine kinase signalling in breast cancer: fibroblast growth factors and their receptors. Breast Cancer Res 2000;2(3):191-6.